White Pine Capital’s Pfizer PFE Stock Holding History

White Pine Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$458K	Buy	16,316 +2,925	+22%	+$77.9K	0.13%	170
2025 Q4	$333K	Sell	13,391 -690	-5%	-$17.4K	0.09%	189
2025 Q3	$359K	Sell	14,081 -98	-0.7%	-$2.42K	0.1%	183
2025 Q2	$344K	Sell	14,179 -4,995	-26%	-$116K	0.11%	180
2025 Q1	$486K	Sell	19,174 -60	-0.3%	-$1.57K	0.17%	143
2024 Q4	$510K	Buy	19,234 +6,196	+48%	+$168K	0.17%	145
2024 Q3	$377K	Buy	13,038 +2,084	+19%	+$60.8K	0.13%	167
2024 Q2	$307K	Buy	+10,954	New	+$302K	0.12%	177
2023 Q4	–	Sell	-6,600	Closed	-$219K	–	209
2023 Q3	$219K	Sell	6,600 -75	-1%	-$2.65K	0.09%	196
2023 Q2	$245K	Sell	6,675 -58	-0.9%	-$2.26K	0.09%	189
2023 Q1	$275K	Sell	6,733 -842	-11%	-$36.4K	0.11%	171
2022 Q4	$388K	Sell	7,575 -470	-6%	-$22.5K	0.15%	146
2022 Q3	$352K	Sell	8,045 -675	-8%	-$32.8K	0.15%	149
2022 Q2	$457K	Sell	8,720 -905	-9%	-$46.1K	0.18%	130
2022 Q1	$498K	Sell	9,625 -6,735	-41%	-$349K	0.15%	147
2021 Q4	$966K	Buy	16,360 +915	+6%	+$45.3K	0.29%	107
2021 Q3	$664K	Hold	15,445	–	–	0.2%	136
2021 Q2	$661K	Buy	15,445 +3,884	+34%	+$151K	0.2%	134
2021 Q1	$419K	Buy	11,561 +2,839	+33%	+$101K	0.13%	161
2020 Q4	$321K	Sell	8,722 -576	-6%	-$21.1K	0.11%	183
2020 Q3	$324K	Hold	9,298	–	–	0.13%	163
2020 Q2	$288K	Buy	9,298 +210	+2%	+$7.13K	0.12%	164
2020 Q1	$281K	Sell	9,088 -1,383	-13%	-$47.1K	0.14%	148
2019 Q4	$389K	Buy	10,471 +843	+9%	+$30K	0.15%	148
2019 Q3	$328K	Sell	9,628 -1,681	-15%	-$61.1K	0.12%	179
2019 Q2	$465K	Sell	11,309 -2,334	-17%	-$92.7K	0.17%	148
2019 Q1	$550K	Sell	13,643 -570	-4%	-$22.8K	0.2%	140
2018 Q4	$589K	Hold	14,213	–	–	0.24%	120
2018 Q3	$594K	Buy	14,213 +1,054	+8%	+$40.6K	0.21%	130
2018 Q2	$453K	Sell	13,159 -132	-1%	-$4.51K	0.16%	160
2018 Q1	$448K	Hold	13,291	–	–	0.17%	155
2017 Q4	$457K	Buy	13,291 +2,016	+18%	+$68.7K	0.17%	148
2017 Q3	$382	Hold	11,275	–	–	﹤0.01%	158
2017 Q2	$359K	Hold	11,275	–	–	0.14%	165
2017 Q1	$366K	Hold	11,275	–	–	0.15%	158
2016 Q4	$347K	Hold	11,275	–	–	0.15%	158
2016 Q3	$362K	Hold	11,275	–	–	0.15%	162
2016 Q2	$377K	Hold	11,275	–	–	0.16%	163
2016 Q1	$317K	Buy	11,275 +1,397	+14%	+$39.9K	0.14%	171
2015 Q4	$303K	Buy	9,878 +105	+1%	+$3.3K	0.13%	171
2015 Q3	$291K	Hold	9,773	–	–	0.14%	179
2015 Q2	$311K	Hold	9,773	–	–	0.13%	175
2015 Q1	$323K	Hold	9,773	–	–	0.13%	172
2014 Q4	$289K	Hold	9,773	–	–	0.1%	187
2014 Q3	$274K	Hold	9,773	–	–	0.09%	192
2014 Q2	$275K	Sell	9,773 -316	-3%	-$9.01K	0.1%	186
2014 Q1	$307K	Hold	10,089	–	–	0.11%	182
2013 Q4	$293K	Sell	10,089 -35	-0.3%	-$1.02K	0.1%	186
2013 Q3	$276K	Hold	10,124	–	–	0.1%	192
2013 Q2	$269K	Buy	+10,124	New	+$280K	0.09%	188

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

White Pine Capital's PFE Position: Q1 2026 in Review

White Pine Capital increased its Pfizer (PFE) stake by 22% in Q1 2026, buying an estimated $77.9K and bringing the position to 16,316 shares worth $458K. The position accounts for 0.13% of the portfolio, ranked #170.

White Pine Capital first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $966K in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

White Pine Capital held 16,316 shares of Pfizer worth $458K as of Q1 2026.
White Pine Capital bought 2,925 Pfizer shares in Q1 2026, an estimated $77.9K.
Pfizer made up 0.13% of White Pine Capital's portfolio in Q1 2026, its #170 holding.
White Pine Capital first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
White Pine Capital's Pfizer position peaked at $966K in Q4 2021.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on White Pine Capital's 13F filing for Q1 2026, filed 11 May 2026.